scholarly article | Q13442814 |
P2093 | author name string | Daniel C Nelson | |
Hongping Wei | |||
Hang Yang | |||
Yunpeng Li | |||
Yuhong Li | |||
Mengyue Wang | |||
Sara B Linden | |||
Xiaoran Shang | |||
Yongli Bi | |||
P2860 | cites work | Effects of glucose and fluoride on competition and metabolism within in vitro dental bacterial communities and biofilms | Q44010769 |
Antibacterial and biofilm removal activity of a podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-wall-degrading enzyme | Q44607884 | ||
Inhibitory effect of some herbal extracts on adherence of Streptococcus mutans | Q44892291 | ||
Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis | Q46602101 | ||
Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens. | Q53802821 | ||
Lytic bacteriophages ofStreptococcus mutans | Q87060424 | ||
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme | Q24609957 | ||
A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method | Q27304933 | ||
Analysis of the effects of chlorhexidine on oral biofilm vitality and structure based on viability profiling and an indicator of membrane integrity. | Q33202197 | ||
Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus | Q33525230 | ||
Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme | Q33555987 | ||
Physico-chemistry of initial microbial adhesive interactions--its mechanisms and methods for study | Q33611476 | ||
Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development | Q33874627 | ||
Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens | Q34114172 | ||
Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats | Q34123647 | ||
Engineered bacteriophage lysins as novel anti-infectives | Q34349552 | ||
Rapid degradation of Streptococcus pyogenes biofilms by PlyC, a bacteriophage-encoded endolysin. | Q34655703 | ||
A review of the efficacy of chlorhexidine on dental caries and the caries infection | Q35106534 | ||
Competence-dependent endogenous DNA rearrangement and uptake of extracellular DNA give a natural variant of Streptococcus mutans without biofilm formation | Q35274076 | ||
Solving the etiology of dental caries | Q35461809 | ||
Application of a bacteriophage lysin to disrupt biofilms formed by the animal pathogen Streptococcus suis | Q35599168 | ||
Isolation of a Novel Phage with Activity against Streptococcus mutans Biofilms. | Q35785449 | ||
Biology and genome sequence of Streptococcus mutans phage M102AD. | Q35827175 | ||
Using a Novel Lysin To Help Control Clostridium difficile Infections | Q36290571 | ||
The role of sucrose in cariogenic dental biofilm formation--new insight | Q36602378 | ||
Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus | Q37026612 | ||
Role of Streptococcus mutans in human dental decay | Q37062855 | ||
Biology, immunology, and cariogenicity of Streptococcus mutans | Q37065366 | ||
Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection | Q37070575 | ||
In vitro destruction of Streptococcus pneumoniae biofilms with bacterial and phage peptidoglycan hydrolases | Q38282910 | ||
Phage lytic proteins: biotechnological applications beyond clinical antimicrobials. | Q38325227 | ||
Functional genomics approach to identifying genes required for biofilm development by Streptococcus mutans. | Q39639225 | ||
Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillin-sensitive and -resistant Streptococcus pneumoniae strains | Q39730777 | ||
Quantification and Correlation of Oral Candida with Caries Index Among Different Age Groups of School Children: A Case-Control Study | Q39744653 | ||
TiF4 and NaF varnishes as anti-erosive agents on enamel and dentin erosion progression in vitro. | Q41247026 | ||
Oral streptococci... products of their environment | Q41718989 | ||
PERIODONTAL LESIONS IN THE SYRIAN HAMSTER. III. FINDINGS RELATED TO AN INFECTIOUS AND TRANSMISSIBLE COMPONENT. | Q43470994 | ||
Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. | Q43511826 | ||
Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase | Q43820230 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Streptococcus mutans | Q131452 |
P304 | page(s) | 7436-7443 | |
P577 | publication date | 2016-10-10 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Antibiofilm Activities of a Novel Chimeolysin against Streptococcus mutans under Physiological and Cariogenic Conditions | |
P478 | volume | 60 |
Q52601747 | A Cell-Penetrating Peptide Fused Phage Lysin Kills Intracellular MRSA in Keratinocytes and Treatment for Skin Infections of Mice. |
Q59356188 | Activity of the Chimeric Lysin ClyR against Common Gram-Positive Oral Microbes and Its Anticaries Efficacy in Rat Models |
Q92377206 | Contributions of Net Charge on the PlyC Endolysin CHAP Domain |
Q55002788 | Curcumin as a Promising Antibacterial Agent: Effects on Metabolism and Biofilm Formation in S. mutans. |
Q59360278 | Effects of a Chimeric Lysin against Planktonic and Sessile Hint at Potential Application in Endodontic Therapy |
Q52642775 | Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials. |
Q39369783 | Targeted antimicrobial therapy in the microbiome era. |
Search more.